VOGLIBITE GM 2/0.2 MG TAB
Rs 160.65 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
VOGLIBITE GM 2/0.2 MG TAB
Voglibite GM 2 Tablets are designed to provide comprehensive relief for symptoms associated with vestibular disorders and Meniere's disease. Each tablet features a blend of 16 mg of Betahistine dihydrochloride and 80 mg of Ginkgo Biloba extract. Betahistine works by improving blood circulation in the inner ear, which helps to stabilize inner ear pressure and alleviate symptoms such as dizziness, vertigo, and tinnitus. Meanwhile, Ginkgo Biloba enhances cognitive function and peripheral circulation, providing additional support. The dual-action formula ensures effective management of symptoms while supporting overall inner ear and cognitive health. Packaged in a 10-tablet supply, Voglibite GM 2 offers a practical solution for both short-term symptom control and ongoing management, contributing to improved quality of life for those affected by vestibular conditions.
Product Highlights and Usage:
Active Ingredients: Each tablet contains 16 mg of Betahistine dihydrochloride and 80 mg of Ginkgo Biloba extract, offering a dual therapeutic approach. Dual Action Formula: Combines Betahistine to improve inner ear circulation and alleviate symptoms like dizziness and vertigo, with Ginkgo Biloba to support cognitive function and enhance peripheral circulation. Effective Symptom Management: Helps reduce symptoms associated with vestibular disorders and Meniere's disease, including dizziness, vertigo, and tinnitus. Convenient Tablet Form: Easy-to-swallow tablets that ensure accurate dosing and convenience for daily use. 10-Tablet Pack: Supplied in a pack of 10 tablets, suitable for both short-term relief and long-term management.
How it works:
VOGLIBITE GM 2 TABLET is used to manage type 2 diabetes mellitus. Glimepiride helps lower blood glucose levels by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and decreases glucose absorption in the stomach and intestines. It also improves the body's response to insulin. Voglibose inhibits the alpha-glucosidase enzyme, which breaks down complex carbohydrates into simple sugars. This action slows the digestion and absorption of carbohydrates in the small intestine, leading to reduced blood glucose levels in individuals with type 2 diabetes mellitus.
Directions for use:
Take VOGLIBITE GM 2 TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY VOGLIBITE GM 2 TABLET is not recommended during pregnancy as it may harm the fetus. Consult your doctor before using it. BREASTFEEDING VOGLIBITE GM 2 TABLET is not recommended for breastfeeding women because it may pass into breast milk and potentially harm the nursing child. Consult your doctor before using it. DRIVING AND USING MACHINES Use VOGLIBITE GM 2 TABLET with caution if you experience impaired alertness or reactions (due to low blood sugar). Avoid driving or operating machinery under these conditions. ALCOHOL Consult your doctor about alcohol consumption while taking VOGLIBITE GM 2 TABLET, as it may lower your blood sugar levels. KIDNEY VOGLIBITE GM 2 TABLET is not recommended for patients with severe renal failure and should be used cautiously in those with other kidney issues. Consult your doctor before use. LIVER VOGLIBITE GM 2 TABLET is not recommended for patients with severe liver disease and should be used cautiously in those with other liver conditions. Consult your doctor before use. ALLERGY Do not use VOGLIBITE GM 2 TABLET if you are allergic to glimepiride, metformin, voglibose, other sulfonylureas/sulphonamides, or any other ingredients of this medication. LUNGS VOGLIBITE GM 2 TABLET is not recommended for patients with lung conditions such as acute or chronic respiratory failure. Consult your doctor before use. HEART DISEASE VOGLIBITE GM 2 TABLET is not recommended for patients with heart conditions such as acute or chronic cardiac failure or recent myocardial infarction. Consult your doctor before use. USE IN PEDIATRICS VOGLIBITE GM 2 TABLET is not recommended for children and adolescents under 18 years, as its safety and effectiveness have not been established. Consult your doctor before use. USE IN GERIATRICS Use VOGLIBITE GM 2 TABLET with caution in elderly patients aged 65 and above. Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$